Deep DiveDermatology / Skin

Contact Dermatitis vs Atopic Dermatitis

Both cause eczematous rash and pruritus. Contact dermatitis maps to an exposure. Atopic dermatitis has a chronic relapsing course, flexural predilection, and a personal or family history of atopy.

Listen to this Deep Dive8 min 55 sec
Contact Dermatitis vs Atopic Dermatitis
0:00/0:00

Both cause eczematous rash and pruritus — but the mechanism, distribution, and course differ. Contact dermatitis maps to an exposure. Atopic dermatitis is a chronic inflammatory condition with flexural predilection and atopy history. The distinction changes the treatment and the conversation with the patient.

CLINICAL PRINTABLE

Coming Soon.

Coming Soon. A one-page Contact vs Atopic Dermatitis clinical reference is on the way.

1 · Recognition

  • Contact dermatitis (irritant): caused by direct chemical damage to the skin barrier. No sensitization required. Common in healthcare workers (frequent handwashing, gloves), industrial workers, and anyone with repeated exposure to soaps, detergents, or solvents. Presents with erythema, dryness, fissuring, and burning at the contact site.
  • Contact dermatitis (allergic): type IV delayed hypersensitivity reaction. Requires prior sensitization. Presents 24–72 hours after re-exposure with pruritic vesicular or eczematous rash at the contact site. Common allergens: nickel (jewelry), fragrances, preservatives (cosmetics), rubber/latex, poison ivy/oak/sumac, neomycin.
  • Atopic dermatitis: chronic relapsing inflammatory skin disease. Associated with personal or family history of asthma, allergic rhinitis, or food allergies (atopic triad). Presents with intensely pruritic eczematous plaques in flexural areas (antecubital fossa, popliteal fossa, neck, wrists) in older children and adults.
  • Key distinguishing features: contact dermatitis — distribution maps the exposure, acute onset after contact, resolves after allergen/irritant removal; atopic dermatitis — chronic relapsing course, flexural distribution, personal/family atopy, begins in childhood.
  • Both can become secondarily infected (impetiginization) — look for honey-colored crusting, increased weeping, and worsening despite appropriate treatment.

2 · Differential / Common Traps

  • Missing the occupational or environmental exposure in contact dermatitis: always ask about occupation, hobbies, new products (soaps, cosmetics, jewelry), and recent environmental exposures. The distribution of the rash is the most important clue.
  • Attributing hand eczema to atopic dermatitis without considering irritant contact dermatitis: healthcare workers with hand eczema most commonly have irritant contact dermatitis from frequent handwashing and glove use — not atopic dermatitis.
  • Missing secondary infection in atopic dermatitis: Staphylococcus aureus colonizes the skin of most atopic dermatitis patients and can trigger flares. Honey-colored crusting, increased weeping, or failure to respond to topical steroids should prompt consideration of secondary infection.
  • Over-treating atopic dermatitis with high-potency topical steroids on the face or intertriginous areas: these sites require low-potency steroids or non-steroidal alternatives (tacrolimus, pimecrolimus) to avoid skin atrophy, striae, and telangiectasias.
  • Confusing nummular eczema with tinea corporis: nummular eczema presents as coin-shaped eczematous plaques that can mimic ringworm. KOH preparation distinguishes them — negative in nummular eczema, positive in tinea.

3 · Workup and Interpretation

  • Clinical diagnosis in most cases — history and distribution are usually sufficient. Patch testing is the gold standard for identifying specific allergens in allergic contact dermatitis.
  • Patch testing: indicated when allergic contact dermatitis is suspected and the allergen is not clinically obvious, or when the condition is not responding to treatment. Performed by dermatology.
  • KOH preparation: when tinea is in the differential (especially for nummular or annular presentations). Negative KOH supports eczematous diagnosis.
  • Skin culture: when secondary bacterial infection is suspected (honey-colored crusting, increased weeping, fever). Staphylococcus aureus is the most common pathogen.
  • IgE levels and specific allergen testing: may support atopic dermatitis diagnosis but are not required for clinical management in most cases.

4 · Treatment / Management

Irritant contact dermatitis

Identify and eliminate the irritant. Barrier protection (gloves, emollients). Topical corticosteroids for active inflammation. Emollient therapy to restore the skin barrier. Behavior modification (reduced frequency of handwashing, gentle cleansers).

Allergic contact dermatitis

Identify and eliminate the allergen — this is the definitive treatment. Topical corticosteroids for localized disease. Systemic corticosteroids (prednisone taper) for severe or widespread involvement. Antihistamines for pruritus. Patch testing for allergen identification when the source is unclear.

Atopic dermatitis — acute flare

Topical corticosteroids (appropriate potency for body site — avoid high-potency on face/intertriginous areas). Wet wrap therapy for severe flares. Antihistamines for pruritus (sedating antihistamines at night). Treat secondary infection if present (topical or oral antibiotics).

Atopic dermatitis — maintenance

Daily emollient application (cornerstone of maintenance). Topical calcineurin inhibitors (tacrolimus, pimecrolimus) for steroid-sparing maintenance. Identify and avoid triggers (irritants, allergens, stress, sweat, certain fabrics). Dupilumab (IL-4/IL-13 inhibitor) for moderate-to-severe disease not controlled with topical therapy.

Secondary infection

Topical mupirocin for localized impetiginization. Oral antibiotics (cephalexin, dicloxacillin) for more extensive secondary infection. Consider MRSA coverage (trimethoprim-sulfamethoxazole, doxycycline) in high-prevalence areas or treatment failure.

5 · Expected Course / Reassessment

  • Irritant contact dermatitis resolves after eliminating the irritant and restoring the skin barrier — typically weeks to months with consistent treatment.
  • Allergic contact dermatitis resolves after allergen removal — typically 2–4 weeks with appropriate treatment. Recurrence is prevented by ongoing allergen avoidance.
  • Atopic dermatitis is a chronic relapsing condition. Many children improve significantly by adolescence, but a substantial proportion continue into adulthood. Flares are managed, not cured.
  • Failure to improve with appropriate topical therapy should prompt reassessment: consider secondary infection, incorrect diagnosis (tinea, psoriasis), allergen not identified, or need for systemic therapy.

6 · Escalation

  • Widespread contact dermatitis not responding to topical therapy — systemic corticosteroids and dermatology referral.
  • Atopic dermatitis with signs of secondary infection (fever, spreading erythema, honey-colored crusting) — systemic antibiotics.
  • Moderate-to-severe atopic dermatitis not controlled with topical therapy — dermatology referral for consideration of dupilumab or other systemic agents.
  • Eczema herpeticum (widespread HSV infection in atopic dermatitis) — presents with punched-out erosions, fever, and rapid spread. Requires urgent systemic antiviral therapy (acyclovir).

Apply It · Patient Cases

CASE 1

A 35-year-old nurse presents with chronic hand eczema — erythema, fissuring, and dryness on the dorsal hands and between the fingers. She washes her hands 50+ times per day. Irritant contact dermatitis from repeated handwashing and glove use is diagnosed. Barrier cream, gentle cleansers, and topical corticosteroids are prescribed. Glove use is modified to reduce friction.

CASE 2

A 42-year-old presents with a pruritic vesicular rash on both earlobes and the neck, appearing 48 hours after wearing new jewelry. The distribution maps the nickel exposure. Allergic contact dermatitis to nickel is diagnosed. The jewelry is removed, topical corticosteroids are prescribed, and patch testing is arranged to confirm nickel allergy.

NOW CHANGE ONE DETAIL

Same patient as Case 2, but the rash is in the antecubital fossae and popliteal fossae, has been present since childhood, and she has a history of asthma. The flexural distribution and atopy history point to atopic dermatitis — not contact dermatitis. Management shifts to emollients, topical corticosteroids, and trigger identification.

Bottom Line

Contact dermatitis maps to an exposure — the distribution tells you the cause. Atopic dermatitis has a chronic relapsing course with flexural predilection and atopy history. Both can be secondarily infected — look for honey-colored crusting.

EVIDENCE & REFERENCES

  1. Fonacier L, et al. Contact Dermatitis: A Practice Parameter Update 2015. J Allergy Clin Immunol Pract. 2015;3(3 Suppl):S1–39. doi:10.1016/j.jaip.2015.02.009
  2. Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–351. doi:10.1016/j.jaad.2013.10.010
  3. Silverberg JI. Public Health Burden and Epidemiology of Atopic Dermatitis. Dermatol Clin. 2017;35(3):283–289. doi:10.1016/j.det.2017.02.002
Back to Deep Dives